Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by MrMugsyon Dec 28, 2020 8:26pm
320 Views
Post# 32189099

RE:RE:Stock up today ...

RE:RE:Stock up today ...
Doccole wrote: I bought today, I'm conflicted because I want it to move up and I want to add as much as possible.

mugs- you think OTEN has a 2b price tag?


Oh it's got a price tag on it !!!
But ... I think there's going ot be a price checker called to aisle P (P for pharma) and it's getting slapped with an even higher price in the next few months.

If I were Dan, I know what I would do to put Big Pharma in a compromising position.  There would be lots of updates coming for shareholders and pharma alike (if I understand the state of our business).  There would be a little partnering in a few geographies, including a small ownership stake exchanged for cash and a double digit future royalty.  This kind of move could net us enough up-front cash to buy a couple years during Phase 3.  It would also show Big Pharma that we can do it with or without them.

Then we just might see some fireworks on the Big Pharma side.

In my opinion only - Can't wait for 2021 !!!

<< Previous
Bullboard Posts
Next >>